Sorbitol Is a Severity Biomarker for PMM2-CDG with Therapeutic Implications.
Ann Neurol
; 90(6): 887-900, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34652821
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rhodanine
/
Sorbitol
/
Phosphotransferases (Phosphomutases)
/
Congenital Disorders of Glycosylation
/
Enzyme Inhibitors
/
Thiazolidines
Type of study:
Prognostic_studies
Aspects:
Patient_preference
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Middle aged
Language:
En
Journal:
Ann Neurol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: